Spots Global Cancer Trial Database for lupron
Every month we try and update this database with for lupron cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Melanoma Vaccine With Peptides and Leuprolide | NCT00254397 | Melanoma | Leuprolide GP100: 209-217(... MAGE-3 Peptide | 18 Years - | M.D. Anderson Cancer Center | |
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | NCT02749825 | Prostate Cancer | Trelstar Lupron Zoladex | 18 Years - | Pharmatech | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | NCT00631527 | Prostate Cancer | Leuprolide Goserelin Sunitinib Malat... Casodex Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | NCT02749825 | Prostate Cancer | Trelstar Lupron Zoladex | 18 Years - | Pharmatech | |
| Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle | NCT00586898 | Prostate Cancer Hormonal Cyclin... | GnRH Ketoconazole Bicalutamide Testosterone tr... Estrogen transd... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | NCT02749825 | Prostate Cancer | Trelstar Lupron Zoladex | 18 Years - | Pharmatech | |
| Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer | NCT00658697 | Prostate Cancer | Docetaxel Bevacizumab ADT Bicalutamide | 18 Years - | Dana-Farber Cancer Institute | |
| A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | NCT03009981 | Prostate Cancer | Apalutamide LHRH Analogue Abiraterone Ace... Prednisone | 18 Years - | Alliance Foundation Trials, LLC. | |
| Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy | NCT00329043 | Prostate Cancer | LHRH Agonist Sunitinib Malat... Radical Prostat... | - | M.D. Anderson Cancer Center | |
| Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy | NCT00329043 | Prostate Cancer | LHRH Agonist Sunitinib Malat... Radical Prostat... | - | M.D. Anderson Cancer Center | |
| Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer | NCT04331717 | Prostate Adenoc... Obesity, Morbid | Bead Block 300-... Weight Manageme... Lupron | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Study of Definitive Therapy to Treat Prostate Cancer | NCT02716974 | Prostate Cancer | Leuprolide Acet... Bicalutamide Docetaxel Prostatectomy Radiation | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00002597 | Prostate Cancer | flutamide Zoladex Lupron radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | NCT00243646 | Prostate Cancer | External beam r... Lupron Casodex | - | Schiffler Cancer Center | |
| A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | NCT03009981 | Prostate Cancer | Apalutamide LHRH Analogue Abiraterone Ace... Prednisone | 18 Years - | Alliance Foundation Trials, LLC. | |
| Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation | NCT01746849 | Leukemia Multiple Myelom... Myelodysplastic... Non-Hodgkin's L... | Palifermin Lupron peripheral bloo... Total-Body Irra... Thiotepa Cyclophosphamid... Degarelix | 18 Years - 60 Years | Memorial Sloan Kettering Cancer Center | |
| Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer | NCT00500110 | Prostate Cancer | Docetaxel Imatinib Mesyla... Leuprolide Goserelin Aceta... | - | M.D. Anderson Cancer Center | |
| A Study of Definitive Therapy to Treat Prostate Cancer | NCT02716974 | Prostate Cancer | Leuprolide Acet... Bicalutamide Docetaxel Prostatectomy Radiation | 18 Years - 80 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | NCT00243646 | Prostate Cancer | External beam r... Lupron Casodex | - | Schiffler Cancer Center | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation | NCT01746849 | Leukemia Multiple Myelom... Myelodysplastic... Non-Hodgkin's L... | Palifermin Lupron peripheral bloo... Total-Body Irra... Thiotepa Cyclophosphamid... Degarelix | 18 Years - 60 Years | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
